Human Plasma Like Medium Market Report 2026

Human Plasma Like Medium Market Overview

• Human Plasma Like Medium market size has reached to $0.91 billion in 2025 • Expected to grow to $1.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Surge In Demand For In?Vitro Diagnostics And Research Fueling The Market Growth Due To Rising Need For Human Plasma?Like Medium • Market Trend: Advancing Cell Culture With Scalable Animal-Free Alternatives, Consistent Growth Support, And Ethical Bioprocessing Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Human Plasma Like Medium Market?

Human plasma like medium is a specialized cell culture medium designed to closely mimic the biochemical composition of human blood plasma. It contains physiologically relevant concentrations of amino acids, salts, glucose, vitamins, metabolites, and growth-supporting components to provide an in-vivo-like environment for cell growth and experimentation. This medium is widely used to improve the physiological relevance, reproducibility, and predictive accuracy of in-vitro cell culture studies in biomedical research, drug discovery, toxicology, and disease modeling. The main product types of human plasma like medium include liquid and powder formats. Liquid human plasma like medium refers to ready-to-use or minimally diluted culture media formulated to closely mimic the biochemical composition of human plasma, providing physiologically relevant conditions for in vitro cell growth, metabolism studies, and translational research. The distribution channels direct sales, distributors and wholesalers, and online platforms and the various applications such as cell culture, drug discovery, regenerative medicine, and others and the key end-users academic and research institutes, biopharmaceutical companies, contract research organizations, hospitals and diagnostic laboratories, and others.

What Is The Human Plasma Like Medium Market Growth Forecast?

The human plasma derived products market size is expected to see strong growth in the next few years. It will grow to $1.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growing demand for immunoglobulin therapies, rising incidence of immunodeficiency diseases, increasing healthcare expenditure on biologics, expansion of plasma fractionation capacity, and growing adoption of plasma-derived products in emerging markets. Major trends in the forecast period include technology advancements in plasma fractionation, innovation in virus inactivation methods, developments in recombinant and hybrid plasma products, research and development in next generation plasma therapies, and integration of digital systems in plasma collection and processing.

Global Human Plasma Like Medium Market Segmentation

1) By Product Type: Liquid, Powder 2) By Distribution Channel: Direct Sales, Distributors And Wholesalers, Online Platforms 3) By Application: Cell Culture, Drug Discovery, Regenerative Medicine, Other Applications 4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Hospitals And Diagnostic Laboratories, Other End-Users Subsegments: 1) By Liquid: Cell Culture Medium, Growth Factor Supplements, Buffer Solutions, Additive Formulations, Stabilizers 2) By Powder: Lyophilized Cell Culture Medium, Protein Supplements, Mineral Blends, Vitamin Formulations, Reconstitution Agents

What Are The Drivers Of The Human Plasma Like Medium Market?

The increasing demand for in‑vitro diagnostics tests is expected to propel the growth of the human plasma‑like medium market going forward. In‑vitro diagnostics (IVD) are laboratory tests performed on biological samples such as blood, tissues, or fluids to detect diseases, monitor health status, and guide treatment decisions. The rise in in‑vitro diagnostics usage is due to an aging population and higher prevalence of chronic and infectious diseases, prompting more diagnostic testing for early detection and management. The human plasma‑like medium supports in‑vitro diagnostics and research by supplying physiologically relevant cell culture media that researchers and laboratories require for accurate disease modeling, therapeutic development, and assay validation. For instance, in March 2025, according to NHS England, a UK-based government health authority, the number of diagnostic tests conducted in Community Diagnostic Centres increased from 1,498,000 in 2023/24 to 2,328,300 in 2024/25, marking a 55.6 % rise year over year. Therefore, the increasing demand for in‑vitro diagnostics and research is driving the growth of the human plasma‑like medium market. The growing demand for gene therapies is expected to propel the growth of the human plasma-like medium market going forward. Gene therapy refers to a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The increasing demand for gene therapy is due to advancements in genetic sequencing and diagnostics, which enable precise identification of disease-causing genes for targeted treatment. Human plasma-like medium supports gene therapy by providing a physiologically relevant environment that improves the viability, growth, and function of cells used in gene delivery and testing. It enhances therapeutic effectiveness by enabling more accurate evaluation of gene expression and treatment responses under conditions that closely mimic the human body. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the growing demand for gene therapies is driving the growth of the human plasma-like medium market.

Key Players In The Global Human Plasma Like Medium Market

Major companies operating in the human plasma like medium market are Thermo Fisher Scientific Inc., Sigma Aldrich Chemicals Private Limited, Sartorius AG, HiMedia Laboratories Private Limited, Biological Industries Israel Beit Haemek Ltd., PAN-Biotech GmbH, AMS Biotechnology (Europe) Ltd., Plasmax LLC, Avam Biotechnologies Ltd.

Global Human Plasma Like Medium Market Trends and Insights

Major companies operating in the human plasma like medium market are focusing on developing innovative culture supplements, such as scalable animal-free alternatives, to improve reproducibility, safety, and ethical compliance in cell culture and biomanufacturing workflows. A scalable animal-free alternative refers to a biologically derived growth medium component that replaces traditional animal-sourced supplements, offering consistent performance without the variability, ethical concerns, and contamination risks associated with animal products. For instance, in April 2025, PL Bioscience Inc., a US-based biotechnology company, developed the artificial human platelet lysate designed for use in cell culture applications as a scalable animal-free alternative to conventional platelet lysate and serum supplements. This engineered medium component supports robust cell proliferation and viability while eliminating reliance on animal-derived sources, making it suitable for translational research, regenerative medicine, and commercial cell therapy manufacturing.

Regional Insights

North America was the largest region in the human plasma like medium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Human Plasma Like Medium Market?

The human plasma like medium market consists of sales of standardized human plasma-like culture media, serum-free plasma-like media, custom-formulated plasma-like media, and specialized supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Human Plasma Like Medium Market Report 2026?

The human plasma like medium market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the human plasma like medium industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.